Steven A. Narod
#187,466
Most Influential Person Now
Steven A. Narod's AcademicInfluence.com Rankings
Steven A. Narodphilosophy Degrees
Philosophy
#12243
World Rank
#16972
Historical Rank
Logic
#9084
World Rank
#11458
Historical Rank

Steven A. Narodbiology Degrees
Biology
#15786
World Rank
#19843
Historical Rank
Genetics
#1873
World Rank
#1990
Historical Rank

Download Badge
Philosophy Biology
Why Is Steven A. Narod Influential?
(Suggest an Edit or Addition)Steven A. Narod's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Risks of cancer in BRCA1-mutation carriers (1994) (1862)
- BRCA1 and BRCA2: 1994 and beyond (2004) (953)
- Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study (2000) (555)
- Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage (1996) (480)
- CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS (1985) (273)
- The impact of family history on early detection of prostate cancer (1995) (193)
- Risk modifiers in carriers of brca1 mutations (1995) (176)
- Why have breast cancer mortality rates declined (2015) (135)
- The genetic epidemiology of BRCA1 (1994) (71)
- BRCA1 and BRCA2 hereditary breast carcinoma phenotypes (1997) (63)
- Increasing incidence of breast cancer in family with BRCA1 mutation (1993) (56)
- Tubal ligation and risk of ovarian cancer (2001) (43)
- On being the right size: a reappraisal of mammography trials in Canada and Sweden (1997) (37)
- Histology of BRCA1-associated ovarian tumours (1994) (35)
- The genetic epidemiology of BRCA1. Breast Cancer Linkage Consortium. (1994) (34)
- Ovarian cancer, oral contraceptives, and BRCA mutations. (2001) (22)
- Linkage analysis of 26 Canadian breast and breast-ovarian cancer families (1995) (21)
- Dysplasia and the natural history of cervical cancer: early results of the Toronto Cohort Study. (1991) (19)
- Survival of patients with breast cancer and BRCA1 mutations (1998) (17)
- Androgen receptor and familial prostate cancer (1995) (16)
- Radiation, genetics and childhood leukaemia. (1990) (15)
- Linkage analysis of 19 French breast cancer families, with five chromosome 17q markers. (1993) (14)
- Ovarian cancer and HRT in the Million Women Study (2007) (13)
- Tamoxifen and risk of endometrial cancer (2001) (12)
- In-vitro fertilisation and family history of breast cancer (1994) (11)
- Counselling under genetic heterogeneity: a practical approach (1991) (9)
- Genes, the environment, and breast cancer (2010) (9)
- Hereditary breast-ovarian cancer: how can we use the new DNA markers to improve patient management? (1993) (9)
- Familial Cancer Management (1996) (7)
- Prophylactic mastectomy in carriers of BRCA mutations. (2001) (6)
- BRCA1 mutations and survival in women with ovarian cancer. (1997) (6)
- Ovarian cancer risk and family history (1997) (5)
- [Neuroblastoma in the Rhone-Alpes area: epidemiologic data]. (1990) (4)
- What options for treatment of hereditary breast cancer? (2002) (4)
- Genetic heterogeneity of early-onset familial breast cancer (1992) (3)
- Family history and colorectal cancer. (1995) (3)
- The banking of DNA for the prevention of genetic disease. (1991) (3)
- Measles vaccination in Haiti. (1986) (3)
- The Effect of Age on Prostate Cancer Survival (2022) (2)
- Screening for ovarian cancer (1999) (1)
- Screening of inherited breast cancer with DNA markers (1993) (1)
- Common genetic susceptibility to DCIS and invasive ductal carcinoma (2016) (0)
- Targets Tamoxifen for women at high risk of breast cancer (2014) (0)
- Familial ovarian carcinoma: pedigree studies and preliminary results from linkage analysis. (1993) (0)
- Tamoxifen's effect in women with breast cancer (2001) (0)
- ORAL CONTRACEPTION AND GENITAL-TRACT MALIGNANCY (1989) (0)
- CANCER GENETICS ’98 Host Susceptibility to Cancer Progression (1998) (0)
- On the road with Henry Lynch (2020) (0)
- Ceromosome 17q linkage studies of 20 french breast and/or ovarian cancer families (1993) (0)
- MP32-13 PATTERNS OF MORTALITY AFTER PROSTATE CANCER: A SEER-BASED ANALYSIS (2021) (0)
- Looking for BRCA1 and BRCA2 mutations in Asian women with breast cancer (2023) (0)
- Decision letter: Increased burden of familial-associated early-onset cancer risk among minority Americans compared to non-Latino Whites (2021) (0)
- MP61-04 LIFE EXPECTANCY AND THE CHOICE OF RADICAL PROSTATECTOMY (2023) (0)
- Cisplatin in breast cancer treatment in BRCA1 carriers (2012) (0)
- Microelements as risk factors for cancer of the lung and larynx (2012) (0)
- Measles vaccination in Haiti [letter] (1986) (0)
- Author response to “a response to ‘personalised medicine and population health: breast and ovarian cancer’” (2019) (0)
- The risk of breast cancer in women with a CHEK2 mutation (2012) (0)
- [Hereditary predisposition for cancer of the breast and the ovary]. (1993) (0)
- P054: Creation of the Ontario Hereditary Cancer Research Network (OHCRN) (2023) (0)
This paper list is powered by the following services: